These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 10904856

  • 21. Role of aldosterone on lung structural remodelling and right ventricular function in congestive heart failure.
    Chabot A, Jiang BH, Shi Y, Tardif JC, Dupuis J.
    BMC Cardiovasc Disord; 2011 Dec 02; 11():72. PubMed ID: 22136321
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Cardiac and vascular fibrosis and hypertrophy in aldosterone-infused rats: role of endothelin-1.
    Park JB, Schiffrin EL.
    Am J Hypertens; 2002 Feb 02; 15(2 Pt 1):164-9. PubMed ID: 11863252
    [Abstract] [Full Text] [Related]

  • 28. Genomic and nongenomic effects of aldosterone in the rat heart: why is spironolactone cardioprotective?
    Chai W, Garrelds IM, Arulmani U, Schoemaker RG, Lamers JM, Danser AH.
    Br J Pharmacol; 2005 Jul 02; 145(5):664-71. PubMed ID: 15834444
    [Abstract] [Full Text] [Related]

  • 29. The renin-angiotensin-aldosterone system and myocardial collagen matrix remodelling in congestive heart failure.
    Brilla CG, Rupp H, Funck R, Maisch B.
    Eur Heart J; 1995 Dec 02; 16 Suppl O():107-9. PubMed ID: 8682074
    [Abstract] [Full Text] [Related]

  • 30. Treatment of congestive heart failure: interfering the aldosterone-cardiac extracellular matrix relationship.
    Zannad F, Dousset B, Alla F.
    Hypertension; 2001 Nov 02; 38(5):1227-32. PubMed ID: 11711528
    [Abstract] [Full Text] [Related]

  • 31. The cardiac structure-function relationship and the renin-angiotensin-aldosterone system in hypertension and heart failure.
    Brilla CG.
    Curr Opin Cardiol; 1994 Jul 02; 9 Suppl 1():S2-10; discussion S10-1. PubMed ID: 7827369
    [Abstract] [Full Text] [Related]

  • 32. Spironolactone prevents cardiac collagen proliferation after myocardial infarction in rats.
    Mill JG, Milanez Mda C, de Resende MM, Gomes Mda G, Leite CM.
    Clin Exp Pharmacol Physiol; 2003 Oct 02; 30(10):739-44. PubMed ID: 14516412
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Prevention of high salt diet-induced cardiac hypertrophy and fibrosis by spironolactone.
    Lal A, Veinot JP, Leenen FH.
    Am J Hypertens; 2003 Apr 02; 16(4):319-23. PubMed ID: 12670750
    [Abstract] [Full Text] [Related]

  • 35. Protective cardiorenal effects of spironolactone in a rodent model of polycystic kidney disease.
    Jeewandara TM, Ameer OZ, Boyd R, Wyse BF, Underwood CF, Phillips JK.
    Clin Exp Pharmacol Physiol; 2015 Apr 02; 42(4):353-60. PubMed ID: 25676668
    [Abstract] [Full Text] [Related]

  • 36. Molecular mechanisms of myocardial remodeling. The role of aldosterone.
    Delcayre C, Swynghedauw B.
    J Mol Cell Cardiol; 2002 Dec 02; 34(12):1577-84. PubMed ID: 12505056
    [Abstract] [Full Text] [Related]

  • 37. Reversal of cardiac and renal fibrosis by pirfenidone and spironolactone in streptozotocin-diabetic rats.
    Miric G, Dallemagne C, Endre Z, Margolin S, Taylor SM, Brown L.
    Br J Pharmacol; 2001 Jul 02; 133(5):687-94. PubMed ID: 11429393
    [Abstract] [Full Text] [Related]

  • 38. Hypertension-induced renal fibrosis and spironolactone response vary by rat strain and mineralocorticoid receptor gene expression.
    Cavallari LH, Fashingbauer LA, Camp JR, King ST, Geenen DL.
    J Renin Angiotensin Aldosterone Syst; 2008 Sep 02; 9(3):146-53. PubMed ID: 18957385
    [Abstract] [Full Text] [Related]

  • 39. [Cardiac structure-function relationship and the renin-angiotensin-aldosterone system in hypertensive heart disease].
    Funck RC, Wilke A, Rupp H, Maisch B, Brilla CG.
    Herz; 1995 Oct 02; 20(5):330-9. PubMed ID: 7498880
    [Abstract] [Full Text] [Related]

  • 40. The spironolactone renaissance.
    Doggrell SA, Brown L.
    Expert Opin Investig Drugs; 2001 May 02; 10(5):943-54. PubMed ID: 11322868
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.